Top compounds associated with response to FZD2


Feature Type Standardized
Nominal ANOVA
mRNA Gemcitabine GDSC1000 pan-cancer AAC 0.13 0.0007
mRNA DMOG GDSC1000 pan-cancer AAC 0.12 0.0007
mRNA paclitaxel gCSI pan-cancer AAC 0.19 0.0007
mRNA staurosporine CTRPv2 pan-cancer AAC 0.27 0.0007
mRNA AZD6244 CCLE pan-cancer AAC -0.16 0.0008
mRNA tamatinib CTRPv2 pan-cancer AAC 0.13 0.0009
mRNA Camptothecin GDSC1000 pan-cancer AAC 0.12 0.0009
mRNA selumetinib:decitabine (4:1 mol/mol) CTRPv2 pan-cancer AAC -0.12 0.001
mRNA selumetinib:navitoclax (8:1 mol/mol) CTRPv2 pan-cancer AAC -0.13 0.001
mRNA thapsigargin GDSC1000 pan-cancer AAC 0.12 0.002
Download CSV